Cheng Huang (Yang Lv)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Ejection Fraction

Neuroendocrine Tumors

Small Cell Lung Cancer

Radiation Therapy

Top Venues

Cancer management and research

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Cheng Huang, Peng Zheng, Yihao Mao, Yuqiu Xu, Wenju Chang, Qi Lin, Meiling Ji, Lechi Ye, Wentao Tang, Jianmin Xu
Intratumor APOL3 delineates a distinctive immunogenic ferroptosis subset with prognosis prediction in colorectal cancer. Cancer science (2023)
Cheng Huang, Qing-Yang Feng, Zhi-Yuan Zhang, Peng Zheng, De-Xiang Zhu, Qi Lin, Si-Min Chen, Yi-Hao Mao, Yu-Qiu Xu, Mei-Ling Ji, Jian-Min Xu, Guo-Dong He
Low ferroptosis score predicts chemotherapy responsiveness and immune-activation in colorectal cancer. Cancer medicine (2022)
Yuqiu Xu, Qingyang Feng, Yijiao Chen, Yihao Mao, Zhiyuan Zhang, Cheng Huang, Peng Zheng, Shanchao Yu, Guodong He, Jianmin Xu
Significance of Surgery in the Treatment of Colorectal Cancer Ovarian Metastases: A Retrospective Case Matching Study. Cancer management and research 13 (2021)
Cheng Huang, Qing-Yang Feng, Ye Wei, Li Ren, QingHai Ye, XiaoYing Wang, YueHong Cui, Tian-Shu Liu, Bo Zhou, MingLiang Wang, ShengXiang Rao, Jian Wang, JianYong Ding, Guo-Dong He, Jian-Min Xu
Benefits of multi-disciplinary treatment strategy on survival of patients with colorectal cancer liver metastasis. Clinical and translational medicine 10 (3) (2020)
Yang Lv, Xu Han, Xue-Feng Xu, Yuan Ji, Yu-Hong Zhou, Hui-Chuan Sun, Jian Zhou, Jia Fan, Wen-Hui Lou, Cheng Huang
Risk factors affecting prognosis in metachronous liver metastases from WHO classification G1 and G2 gastroenteropancreatic neuroendocrine tumors after initial R0 surgical resection. BMC cancer 19 (1) (2019)